TSLP and acute lymphoblastic leukemia: Remarkably, our combined data from exome sequencing [20], and primary ALL cell protein signaling (presented in this study), suggest that up to 65–82% of DS-ALL cases have highly activated RAS, either constitutively, or upon TSLP induction, regardless of their mutation profiles.